Drugs / ABT-712
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00935311 | Jun → Aug 2009 | — | AbbVie | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT00763321 | Sep 2008 → Apr 2009 | chronic pain syndrome | AbbVie | Completed | No outcome recorded |
| Phase 3 | NCT00761150 | Sep 2008 → Mar 2009 | chronic pain syndrome | AbbVie | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ABT-712 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00761150 ↗ |